EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
EVFM
Delisted
EVFM was delisted on the 10th of August, 2022.
62 hedge funds and large institutions have $8.84M invested in Evofem Biosciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
55% less capital invested
Capital invested by funds: $19.8M → $8.84M (-$10.9M)
Holders
62
Holding in Top 10
–
Calls
$963K
Puts
$285K
Top Buyers
| 1 | +$324K | |
| 2 | +$86.3K | |
| 3 | +$53K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$48.2K |
| 5 |
MCP
Mirador Capital Partners
Pleasanton,
California
|
+$25.2K |
Top Sellers
| 1 | -$841K | |
| 2 | -$798K | |
| 3 | -$115K | |
| 4 |
TAM
Tocqueville Asset Management
New York
|
-$112K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$55.9K |